Bile acid signaling in metabolic and inflammatory diseases and drug development

T Li, JYL Chiang, G Guo - Pharmacological Reviews, 2024 - Elsevier
Bile acids are the end products of cholesterol catabolism. Hepatic bile acid synthesis
accounts for a major fraction of daily cholesterol turnover in humans. Biliary secretion of bile …

[HTML][HTML] Acute kidney injury in patients with Cirrhosis: Acute Disease Quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus …

MK Nadim, JA Kellum, L Forni, C Francoz, SK Asrani… - Journal of …, 2024 - Elsevier
Patients with cirrhosis are prone to develop acute kidney injury (AKI), a complication
associated with a markedly increased in-hospital morbidity and mortality, along with a risk of …

[HTML][HTML] Role of WISP1 in Stellate Cell Migration and Liver Fibrosis

D González, G Campos, L Pütter, A Friebel… - Cells, 2024 - mdpi.com
The mechanisms underlying the remarkable capacity of the liver to regenerate are still not
completely understood. Particularly, the cross-talk between cytokines and cellular …

Epithelial Na+ channel activation after bile duct ligation with mineralocorticoid receptor blockade

XP Wang, SM Mutchler… - Journal of the …, 2024 - journals.lww.com
Background: Sodium and fluid retention in liver disease are classically thought to result from
reduced effective circulating volume and stimulation of the renin-angiotensin-aldosterone …

Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials

WFJ Hof, JF de Boer, HJ Verkade - Expert Opinion on Emerging …, 2024 - Taylor & Francis
Introduction Progressive familial intrahepatic cholestasis (PFIC) is a group of disorders
characterized by inappropriate bile formation, causing hepatic accumulation of bile acids …

Targeting bile salt homeostasis in biliary diseases

DC Trampert, RF Kunst… - Current opinion in …, 2024 - journals.lww.com
Modulating bile salt homeostasis has proven a promising treatment strategy in models of
cholestasis and are continuously being further developed. Confirmatory clinical studies are …

Acetaminophen overdose causes a breach of the blood–bile barrier in mice but not in rats

R Hassan, Z Hobloss, M Myllys, D González… - Archives of …, 2024 - Springer
Acetaminophen (APAP) is known to cause a breach of the blood–bile barrier in mice that, via
a mechanism called futile bile acid (BA) cycling, increases BA concentrations in hepatocytes …

What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches

M Pinon, BM Kamath - Current Opinion in Pediatrics, 2024 - journals.lww.com
Next-generation sequencing (NGS) technologies have revolutionized diagnostic
approaches, while discovery of new intracellular signaling pathways show promise in …

[HTML][HTML] Bile acid metabolism and signalling in liver disease

CD Fuchs, B Simbrunner, M Baumgartner… - Journal of …, 2024 - Elsevier
Bile acids (BAs) serve as signalling molecules, efficiently regulating their own metabolism
and transport, as well as key aspects of lipid and glucose homeostasis. BAs shape the gut …

Structure–Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT

M Wannowius, C Neelen, P Lotz, M Daude… - Journal of Medicinal …, 2024 - ACS Publications
The intestinal bile acid carrier ASBT (SLC10A2), the hepatic bile acid carrier NTCP
(SLC10A1), and the steroid sulfate carrier SOAT (SLC10A6), all members of the solute …